CHU de CAEN

Running trials

• Not yet recruiting

  Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A

  NCT07830693· Source

• Not yet recruiting

  Real World Positioning of Tyrosine Kinase Inhibitors (TKIs) Within Systemic Treatment Strategies for Advanced Neuroendocrine Tumors (NETs)

  NCT07890012· Source

• Recruiting

  Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

  NCT07418827· Source

• Recruiting

  Study of Patient Preferences in Dialysis Treatment Choice: a Discrete Choice Experiment

  NCT07535320· Source

• Recruiting

  ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

  NCT07191730· Source

• Not yet recruiting

  Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

  NCT06798532· Source

• Recruiting

  Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

  NCT06943469· Source

• Recruiting

  Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Patients Treated With Bictegravir

  NCT06902142· Source

• Recruiting

  Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)

  NCT06045819· Source

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Source

• Recruiting

  Benefit of Permanent Stimulation of the Left Branch of the His Bundle Versus Right Ventricular Stimulation After Atrioventricular Node Ablation for Rapid Atrial Fibrillation

  NCT06061978· Source

• Recruiting

  Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients

  NCT05850130· Source

• Active, not recruiting

  A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development

  NCT06055725· Source

• Recruiting

  Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)

  NCT06047600· Source

• Recruiting

  Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

  NCT05945524· Source

• Recruiting

  Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety

  NCT06035211· Source

• Recruiting

  A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

  NCT05689151· Source

• Recruiting

  Rheopheresis as Adjuvant Treatment of Calciphylaxis

  NCT04654000· Source

• Recruiting

  MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

  NCT05691608· Source

• Active, not recruiting

  Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin

  NCT05514028· Source

• Active, not recruiting

  UPLC-MS/MS Monitoring of Emicizumab Therapy

  NCT04472169· Source

• Recruiting

  Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

  NCT05773638· Source

• Recruiting

  Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

  NCT04535349· Source

• Recruiting

  Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies

  NCT04261192· Source

• Active, not recruiting

  Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

  NCT03981003· Source

• Active, not recruiting

  OFSEP High Definition Cohort

  NCT03603457· Source

• Active, not recruiting

  Two Chemotherapy Regimens Plus or Minus Bevacizumab

  NCT03351296· Phase 2· Source

• Active, not recruiting

  International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

  NCT03386734· Source

• Active, not recruiting

  A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

  NCT03223961· Phase 3· Source

• Recruiting

  French National Database of Rare Dermatological Cancers

  NCT03210935· Source

• Recruiting

  Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

  NCT02828202· Source

• Active, not recruiting

  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

  NCT00005584· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers4 recruiting
• Acute myeloid leukemia2 recruiting
• Atopic dermatitis (eczema)2 recruiting
• Atrial fibrillation2 recruiting
• Chronic kidney disease2 recruiting
• Haemophilia2 recruiting
• Kidney cancer2 recruiting
• Amyloidosis1 recruiting
• Colorectal cancer1 recruiting
• Gastric and esophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• HIV1 recruiting
• Liver and biliary tract cancer1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroblastoma1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· Source

• Completed

  Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis

  NCT06024135· Source

• Completed

  PortoSinusoidal Vascular Diseases and Systemic Sclerosis

  NCT06032754· Source

• Completed

  Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT

  NCT05524324· Source

• Completed

  Partial Nephrectomy in Low Pressure

  NCT05404685· Source

• Completed

  Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry

  NCT05218772· Source

• Completed

  Multicenter Validation of the Salivary miRNA Signature of Endometriosis

  NCT05244668· Source

• Completed

  Risk Factors for Portosinusoidal Vascular Disease in Kidney Transplant Recipients:

  NCT05388409· Source

• Terminated

  Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

  NCT04778397· Phase 3· Source

• Completed

  Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)

  NCT06416683· Source

• Completed

  Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

  NCT03808805· Phase 3· Source

• Completed

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· Phase 3· Source

• Recruiting

  Neurovascular Product Surveillance Registry

  NCT02988128· Source

• Completed

  Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance

  NCT02896582· Phase 2· Source

• Terminated

  Relationship Between Left Ventricular Remodeling, Coronary Endothelial Function and Myocardial Fibrosis Using Positron Emission Tomography in Patients With ST-elevation Myocardial Infarction

  NCT02789098· Source

• Completed

  Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

  NCT02576496· Phase 1· Source